Investigating The Flux of Covid-19 Viral Load and It’s Impact on Severity

Authors

  • Urfa Tabassum Kayani Department of Molecular Medicine, Ziauddin University 4/B Shahrah-e-Ghalib Rd, Block 6 Clifton, Karachi, Pakistan
  • Santosh Kumar Sidhwani Department of Pathology, Ziauddin University 4/B Shahrah-e-Ghalib Rd, Block 6 Clifton, Karachi, Pakistan.
  • Nida Hussain Department of Medicine, Ziauddin University 4/B Shahrah-e-Ghalib Rd, Block 6 Clifton, Karachi, Pakistan
  • Ambrina Khatoon Department of Molecular Medicine, Ziauddin University 4/B Shahrah-e-Ghalib Rd, Block 6 Clifton, Karachi, Pakistan
  • Ashok Kumar Department of Pulmonology, Ziauddin University &hospital 4/B Shahrah-e-Ghalib Rd, Block 6 Clifton, Karachi, Pakistan, Sindh 75000 Pakistan
  • Talat Mirza Department of Molecular Medicine, Ziauddin University 4/B Shahrah-e-Ghalib Rd, Block 6 Clifton, Karachi, Pakistan

DOI:

https://doi.org/10.46568/bios.v5i2-3-4.195

Keywords:

COVID-19, Viral load, Clinical course

Abstract

Amidst the Coronavirus disease -2019 (COVID-19) pandemic, understanding viral load's significance for global patient outcomes is crucial. The strain from SARS-CoV-2 underscores the urgency of deciphering its impact on disease severity. This cross-section study, conducted at Ziauddin University between April and September 2021, aims to investigate the potential correlation between COVID-19 viral load, measured by RT PCR CT values, and disease severity and outcome. A total of 103 COVID-19 patients identified via PCR testing, were enrolled, and their demographic data were collected from electronic records. Viral load analysis was conducted using multiplex PCR post-RNA extraction. Ethical considerations, including informed consent and approval from the Ethical Review Committee (ERC), were diligently followed throughout the study. Top of Form the majority of PCR-positive patients exhibited severe (26.2%) or moderate (26.2%) disease, with a higher prevalence among males (52.8%) and those aged 50 years or older (74.8%). Our analysis found no statistically significant difference in viral load among different severity groups. Despite the lack of significant differences, Viral load tended to increase with the Severity of COVID-19. Furthermore, no statistical difference in means of viral load concerning age and gender was observed. In conclusion, while the viral load may increase with disease severity, our findings suggest no significant relationship between the viral load and the severity of COVID-19 in this study, providing important insights into the understanding of disease progression and its clinical management.

References

van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, et al. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol. 2021;254(4):307–31.

Chandir S, Siddiqi DA, Mehmood M, Setayesh H, Siddique M, Mirza A, et al. Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data. Vaccine. 2020 Oct 21;38(45):7146–55.

Atique M, Ghafoor A, Javed R, Fatima N, Yousaf A, Zahra S, et al. Correlation of Viral Load With the Clinical and Biochemical Profiles of COVID-19 Patients. Cureus [Internet]. 2021 Jul 27 [cited 2023 Mar 7];13(7). Available from: https://www.cureus.com/articles/61244-correlation-of-viral-load-with-the-clinical-and-biochemical-profiles-of-covid-19-patients

Subbarao K, Mahanty S. Respiratory Virus Infections: Understanding COVID-19. Immunity. 2020 Jun 16;52(6):905–9.

Waller H, Carmona‐Vicente N, James A, Govender M, Hopkins FR, Larsson M, et al. Viral load at hospitalization is an independent predictor of severe COVID‐19. Eur J Clin Invest [Internet]. 2023 Jan [cited 2023 Dec 2];53(1):e13882. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874715/

Ramirez-Hinojosa JP, Rodriguez-Sanchez Y, Romero-Gonzalez AK, Chavez-Gutierrez M, Gonzalez-Arenas NR, Ibarra-Arce A, et al. Association between cycle threshold (Ct) values and clinical and laboratory data in inpatients with COVID-19 and asymptomatic health workers. J Med Virol [Internet]. 2021 [cited 2024 Jan 19];93(10):5969–76. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27170

Rao SN, Manissero D, Steele VR, Pareja J. A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19. Infect Dis Ther [Internet]. 2020 Sep 1 [cited 2024 May 7];9(3):573–86. Available from: https://doi.org/10.1007/s40121-020-00324-3

Juanola-Falgarona M, Peñarrubia L, Jiménez-Guzmán S, Porco R, Congost-Teixidor C, Varo-Velázquez M, et al. Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using the QIAstat-Dx® Respiratory SARS-CoV-2 Panel. Int J Infect Dis [Internet]. 2022 Sep 1 [cited 2024 May 8];122:930–5. Available from: https://www.sciencedirect.com/science/article/pii/S1201971222004192

Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med [Internet]. 2020 Mar 19 [cited 2024 Feb 23];382(12):1177–9. Available from: https://doi.org/10.1056/NEJMc2001737

Zacharioudakis IM, Prasad PJ, Zervou FN, Basu A, Inglima K, Weisenberg SA, et al. Association of SARS-CoV-2 Genomic Load with Outcomes in Patients with COVID-19. Ann Am Thorac Soc [Internet]. 2021 May [cited 2024 Feb 23];18(5):900–3. Available from: https://www.atsjournals.org/doi/10.1513/AnnalsATS.202008-931RL

CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2024 May 8]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/index.html

Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020 Jan 23;25(3):2000045.

van den Brand JMA, Smits SL, Haagmans BL. Pathogenesis of Middle East respiratory syndrome coronavirus. J Pathol. 2015 Jan;235(2):175–84.

Tabernero E, Ruiz LA, España PP, Méndez R, Serrano L, Santos B, et al. COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences. Infection [Internet]. 2022 Feb 1 [cited 2024 Feb 24];50(1):179–89. Available from: https://doi.org/10.1007/s15010-021-01684-9

Udwadia Z, Tripathi A, Nanda V, Joshi S. Prognostic Factors for Adverse Outcomes in COVID-19 Infection. J Assoc Physicians India. 2020 Jul 1;July edition.

Chinnadurai R, Ogedengbe O, Agarwal P, Money-Coomes S, Abdurrahman AZ, Mohammed S, et al. Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study. BMC Geriatr [Internet]. 2020 Oct 16 [cited 2024 Feb 24];20(1):409. Available from: https://doi.org/10.1186/s12877-020-01803-5

Hasanoglu I, Korukluoglu G, Asilturk D, Cosgun Y, Kalem AK, Altas AB, et al. Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg. Infection. 2021 Feb;49(1):117–26.

Abdulrahman A, Mallah SI, Alqahtani M. COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study. BMC Infect Dis [Internet]. 2021 Jul 16 [cited 2023 Dec 2]; 21:688. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284033/

Argyropoulos KV, Serrano A, Hu J, Black M, Feng X, Shen G, et al. Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients with Outcome and Symptoms. Am J Pathol [Internet]. 2020 Sep 1 [cited 2024 Feb 23];190(9):1881–7. Available from: https://ajp.amjpathol.org/article/S0002-9440(20)30328-X/fulltext

Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun [Internet]. 2020 Oct 30 [cited 2023 Dec 4];11(1):5493. Available from: https://www.nature.com/articles/s41467-020-19057-5

Tsukagoshi H, Shinoda D, Saito M, Okayama K, Sada M, Kimura H, et al. Relationships between Viral Load and the Clinical Course of COVID-19. Viruses [Internet]. 2021 Feb [cited 2024 Feb 24];13(2):304. Available from: https://www.mdpi.com/1999-4915/13/2/304

Burgess S, Smith D, Kenyon JC, Gill D. Lightening the viral load to lessen covid-19 severity. BMJ. 2020 Dec 10;371:m4763.

Boef AGC, van Wezel EM, Gard L, Netkova K, Lokate M, van der Voort PHJ, et al. Viral load dynamics in intubated patients with COVID-19 admitted to the intensive care unit. J Crit Care. 2021 Aug; 64:219–25.

Mossa-Basha M, Medverd J, Linnau KF, Lynch JB, Wener MH, Kicska G, et al. Policies and Guidelines for COVID-19 Preparedness: Experiences from the University of Washington. Radiology. 2020 Aug;296(2): E26–31.

Samadizadeh S, Masoudi M, Rastegar M, Salimi V, Shahbaz MB, Tahamtan A. COVID-19: Why does disease severity vary among individuals? Respir Med [Internet]. 2021 May [cited 2024 Feb 24]; 180:106356. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934673/

Levine-Tiefenbrun M, Yelin I, Katz R, Herzel E, Golan Z, Schreiber L, et al. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat Med [Internet]. 2021 May [cited 2024 May 8];27(5):790–2. Available from: https://www.nature.com/articles/s41591-021-01316-7

Zsichla L, Müller V. Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors. Viruses [Internet]. 2023 Jan [cited 2024 Feb 24];15(1):175. Available from: https://www.mdpi.com/1999-4915/15/1/175.

Published

2024-09-30

How to Cite

Urfa Tabassum Kayani, Santosh Kumar Sidhwani, Nida Hussain, Ambrina Khatoon, Ashok Kumar, & Talat Mirza. (2024). Investigating The Flux of Covid-19 Viral Load and It’s Impact on Severity. BioSight, 5(2-3-4). https://doi.org/10.46568/bios.v5i2-3-4.195

Issue

Section

Original Article

Most read articles by the same author(s)

Similar Articles

<< < 1 2 3 > >> 

You may also start an advanced similarity search for this article.